The rst paradigm shift: never before has adipose tissue been so active While considered a passive lipid storage-release tissue by most cell biologists and pathologists for a long period of time, adipose tissue is now appreciated as the biggest endocrine and paracrine organ of the human body (1-7) ( Table 1 ). e discovery of leptin, an ob/ob gene encoded adipocyte-secreted cytokine, by Je rey Friedman and colleagues in 1994 (1) marked this revolutionary event, which opened the rst adipose-brain talk (Table 2) . Here the pioneering contribution of Douglas Coleman has to be acknowledged. His work established the rst clues to a genetic component in obesity. In the 1970s, Coleman conducted a series of experiments that led him to propose the existence of a satiety factor that would account for obesity and type 2 diabetes among certain laboratory mice.
Onward, it is demonstrated that adipose tissue is able to send and receive di erent types of protein and non-protein signals, thus communicating with many organs in the body. And, in effect, contributing to the control of lipid and glucose metabolism, in ammation, immunity, reproduction, hemostasis, vascular smooth muscle contraction-relaxation, learning, memory and emotions among many other biological functions. Altogether, this matter was conceptualized in two novel research elds, adipobiology and adipopharmacology (2, 4) .
The second paradigm shift: external versus internal adipose depot is paradigm shi derived from the study of Je rey Bell and colleagues (8) who have scanned nearly 800 people with magnetic resonance imaging (MRI) technique, aimed at obtaining Table 1 . An example of paradigm shifts in studying adipose tissue*
FROM
The adipose tissue is a lipid storage-release organ involved in obesity TO Adipose tissue is an endocrine, paracrine and autocrine organ Adipose tissue is a neuroendocrine organ Adipose tissue is a steroidogenic organ Adipose tissue is an immune organ Adipose tissue is a source of and target for in ammatory mediators Adipose tissue produces all components of rennin-angiotensin system Adipose tissue is a storage-release organ of xenobiotics, xenobiotic-metabolizing cytochromes P450 being expressed in adipose tissue** Adipose tissue is thus involved in numerous diseases beyond obesity -Atherosclerosis, Hypertension, Type 2 diabetes, Nonalcoholic fatty liver disease, Polycystic ovarian syndrome, Obstructive sleep apnea syndrome***, Cancer, Osteoarthritis, Alzheimer's disease, Depression *Modi ed from (6). **See (7), also Carmen Purdel and colleagues' review in this volume of Adipobiology. *** See Gülnur Ozturk and colleagues' review in this volume of Adipobiology. (Table 3) . Noteworthy, TOFI phenotype was also found among people who are professional models. TOFI may thus be considered a speci c, "invisible" expression of both Homo obesus and Homo diabesus (6, 9). 
The third paradigm shift: white versus brown adipocytes
is paradigm shi features the increasing signi cance of brown adipose tissue in health and disease.
Adipose tissue is a very plastic tissue, being constantly remodeled along with weight gain and weight loss. It is a dynamic cellular and extracellular matrix assembly composed of adipocytes, stromal vascular cells ( broblasts, endothelial cells, macrophage, mast cells and other immune cells) and matrix components, also rich in sympathetic nerve bers, blood vessels, and stem cells, the latter being with great regenerative power. In human body, there are two major subtypes of adipose tissue, white adipose tissue (WAT) and brown adipose tissue (BAT). While WAT stores energy, BAT has the ability to dissipate energy by producing heat. BAT-mediated increase in energy expenditure is realized by uncoupling respiration from ATP synthesis via uncoupling protein 1 (UCP1), which is the signature protein of brown adipocytes.
Until 10-15 years ago BAT was considered to be biologically active in neonates and young children generating heat during cold exposure by adaptive thermogenesis to maintain normal body temperature. And then regressed with aging by transforming into WAT. At that time, it was demonstrated with 18 F-uorodeoxyglucose (FDG), an intravenously administered radioactive glucose analog, in positron emission tomography (PET) and computed tomography (CT) (PET-CT fusion) scans that the main BAT depots were disseminated throughout the human body (around the aorta, common carotid artery, brachiocephalic artery, kidney, adrenal glands, liver, pancreas; in anterior mediastinum, supraclavicular fossa, axilla and thoracic paravertebral loci, also between neck muscles). e magnitude of 18 FDG uptake by BAT was reported to increase with exposure to low temperature, to be higher in women than men, and to decrease with age and body fat mass (reviewed in 10, 11) .
Animal studies have shown that activation of BAT counteracts diet-induced weight gain and related disorders such as type 2 diabetes and metabolic syndrome; it may also be the case for humans (10) (11) (12) . e knowledge about WAT and BAT were enriched with their relatives, namely brite (brown in white) and bruscle (brown in skeletal muscle) adipocytes (13) .
Taken together, brown adipobiology as well as stem cell adipobiology became new, optimistic challenges in biomedical research.
The emerging fourth shift: adipose-Alzheimer?
Recent results have revealed that adipose cells secrete various neurotrophic factors, including nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) (14-16; 17 for the role of NGF in amyloid precursor protein/APP processing) (Table 4) . Likewise, a growing body of evidence demonstrated a link between obesity, adipokines and the pathogenesis of Alzheimer's disease (18) (19) (20) (21) (22) . Noteworthy, it was found an extraneuronal production of APP including in the adipose tissue (23) (24) (25) . Further, streptozotocin model of inducing experimental diabetes (26) is now also applying in the induction of Alzheimer's disease (27, 28) . us, the hypothesis of adipose tissue as a third brain (29) and consequently of adipose-Alzheimer may sounds more plausible at present. 
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